In vivo antimalarial action of a lipophilic iron (III) chelator: Suppression of plasmodium vinckei infection by reversed siderophore

Simon D. Lytton, Mark Loyevsky, Brenda Mester, Jacqueline Libman, Irene Landau, Abraham Shanzer, Z. Ioav Cabantchik*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

We assessed in vivo antimalarial action of a lipophilic iron (III) chelator belonging to a new synthetic family of biomimetic siderophores previously termed reversed siderophores (RSFs). The family member, RSF ileum2, was chosen for its high membrane permeability and fast irreversible inhibition of human malaria parasite growth in vitro. [Shanzer A, et al., Proc Natl Acad Sci USA 88:6585, 1991 and Lytton SD, et al., Blood 81:214, 1993]. The lipophilic drug was administered to Swiss mice by subcutaneous route in fractionated coconut oil at a dosage of 0.37 g/kg every 8 hr with no adverse reactions observed. After 3–4 injections demonstrable suppression of Plasmodium vinckei petteri infection was observed and an additional 3–4 injections resulted in 2–3‐fold lower parasitemia with prolonged survival time over sham‐injected control mice.

Original languageEnglish
Pages (from-to)217-220
Number of pages4
JournalAmerican Journal of Hematology
Volume43
Issue number3
DOIs
StatePublished - Jul 1993

Keywords

  • Chemotherapy
  • erythrocyte Plasmodium vinckei
  • iron
  • malaria
  • rodent

Fingerprint

Dive into the research topics of 'In vivo antimalarial action of a lipophilic iron (III) chelator: Suppression of plasmodium vinckei infection by reversed siderophore'. Together they form a unique fingerprint.

Cite this